rs745856938

chr12-2493226-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2 PP2 BP4_Moderate

The NM_000719.7(CACNA1C):c.953T>C(p.Leu318Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

• Frequency:
  • Genomes: not found (cov: 33)
  • Exomes 𝑓: 0.0000021 (0 hom.)
• Consequence: CACNA1C NM_000719.7 missense
• Clinical Significance: Uncertain significance criteria provided, multiple submitters, no conflicts U:2
• Conservation: PhyloP100: 2.66

Genes affected

CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]

ACMG classification

Verdict is Uncertain_significance. Variant got 1 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP2: Missense variant where missense usually causes diseases, CACNA1C
• BP4: Computational evidence support a benign effect (MetaRNN=0.24092394).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CACNA1C	NM_000719.7	c.953T>C	p.Leu318Pro	missense_variant	7/47	ENST00000399655.6
CACNA1C	NM_001167623.2	c.953T>C	p.Leu318Pro	missense_variant	7/47	ENST00000399603.6

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
CACNA1C	ENST00000399603.6	c.953T>C	p.Leu318Pro	missense_variant	7/47	5	NM_001167623.2
CACNA1C	ENST00000399655.6	c.953T>C	p.Leu318Pro	missense_variant	7/47	1	NM_000719.7

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD3 exomes AF: 0.00000804 AC: 2 AN: 248838 Hom.: 0 AF XY: 0.00 AC XY: 0 AN XY: 135018

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.00

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000178

Gnomad OTH exome AF: 0.00

GnomAD4 exome AF: 0.00000205 AC: 3 AN: 1461678 Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1 AN XY: 727120

Gnomad4 AFR exome AF: 0.00

Gnomad4 AMR exome AF: 0.00

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.00

Gnomad4 NFE exome AF: 0.00000270

Gnomad4 OTH exome AF: 0.00

GnomAD4 genome Cov.: 33

ExAC AF: 0.00000825 AC: 1

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Long QT syndrome Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Invitae

Mar 28, 2017

In summary, this variant is a rare missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This variant is present in population databases (rs745856938, ExAC 0.002%) but has not been reported in the literature in individuals with a CACNA1C-related disease. This sequence change replaces leucine with proline at codon 318 of the CACNA1C protein (p.Leu318Pro). The leucine residue is weakly conserved and there is a moderate physicochemical difference between leucine and proline. -

Cardiovascular phenotype Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Jul 20, 2022

The p.L318P variant (also known as c.953T>C), located in coding exon 7 of the CACNA1C gene, results from a T to C substitution at nucleotide position 953. The leucine at codon 318 is replaced by proline, an amino acid with similar properties. According to data from gnomAD, the frequency for this variant is above the maximum credible frequency for a cardiac disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association with CACNA1C-related arrhythmia is unlikely. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
CardioboostArm	Benign	0.0000077
BayesDel_addAF	Uncertain	0.055	T
BayesDel_noAF	Benign	-0.16
Cadd	Benign	23
Dann	Benign	0.96
DEOGEN2	Uncertain	0.53	D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen	Benign	-0.35
Eigen_PC	Benign	-0.20
FATHMM_MKL	Benign	0.41	N
M_CAP	Uncertain	0.20	D
MetaRNN	Benign	0.24	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM	Uncertain	0.24	D
MutationTaster	Benign	0.98	N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
PrimateAI	Uncertain	0.58	T
PROVEAN	Uncertain	-2.5	N;N;N;D;N;D;N;N;N;D;N;D;N;N;N;D;N;D;N;N;D;N;N
REVEL	Uncertain	0.34
Sift	Benign	0.25	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G	Benign	0.33	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen		0.0, 1.0, 0.0010	.;B;.;B;B;B;B;B;B;B;B;B;B;B;D;B;.;B;B;.;.;.;B
Vest4		0.21
MutPred		0.59		Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);Gain of catalytic residue at P315 (P = 0);
MVP		0.74
MPC		1.6
ClinPred		0.30	T
GERP RS		5.1
gMVP		0.96

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs745856938; hg19: chr12-2602392;